TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Herb Pharma Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
316
|
351
|
296 |
| Financial expenses |
1
|
2
|
2 |
| Earnings before taxes |
-14
|
-13
|
-3 |
| EBITDA |
-2
|
5
|
9 |
| Total assets |
224
|
272
|
330 |
| Current assets |
197
|
233
|
276 |
| Current liabilities |
80
|
95
|
128 |
| Equity capital |
136
|
153
|
163 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
60.7%
|
56.2%
|
49.4% |
| Turnover per employee |
158
|
176
|
148 |
| Profit as a percentage of turnover |
-4.4%
|
-3.7%
|
-1.0% |
| Return on assets (ROA) |
-5.8%
|
-4.0%
|
-0.3% |
| Current ratio |
246.2%
|
245.3%
|
215.6% |
| Return on equity (ROE) |
-10.3%
|
-8.5%
|
-1.8% |
| Change turnover |
-24
|
54
|
42 |
| Change turnover % |
-7%
|
18%
|
16% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
100% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.